On Tuesday, the Supreme Court heard oral arguments in a case that will determine if nationwide restrictions are imposed on access to mifepristone, a safe medication used in more than half of all U.S. abortions, and for miscarriage treatment. What the court decides later this year will have significant implications on our ability to access abortion, no matter where you live, even in states with legal protections for abortion. The decision could also impact how other medications are protected from interference -- that is, the court could decide that anyone who doesn’t like a certain medication can levy a lawsuit to block access to the drug. To unpack what we heard, we have Julia Kaye, Senior Staff Attorney at the ACLU’s Reproductive Freedom Project who is on site in Washington, D.C. and is joining us just hours after hearing the arguments live.